Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Friday, March 29, 2024 · 699,695,282 Articles · 3+ Million Readers

High-density Multiplexed Diagnostic Assays Market 2017 Global Share, Trend, Segmentation and Forecast to 2021

The analysts forecast the global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.

PUNE, INDIA, June 27, 2017 /EINPresswire.com/ --

Global High-density Multiplexed Diagnostic Assays Market

Description

A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. It is distinguished from procedures that measure one analyte at a time. The assay is one of the diagnostic procedures performed in the laboratory, pharmacology, molecular biology, and various other medical procedures. Different types of assays are performed for the detection and diagnosis of patient's sample.


Covered in this report 
The report covers the present scenario and the growth prospects of the global high density multiplexed diagnostic assays market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

 

Get sample Report @  https://www.wiseguyreports.com/sample-request/1482538-global-high-density-multiplexed-diagnostic-assays-market-2017-2021

 

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

The Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Thermo Fisher Scientific 
• Abbott 
• F. Hoffmann-La Roche

Other prominent vendors 
• Agilent Technologies 
• Bio-Rad Laboratories 
• Erba Diagnostics 
• GOLD STANDARD DIAGNOSTICS 
• Hologic 
• Luminex 
• Randox Laboratories

Market driver 
• Increasing equipment rental agreements 
• For a full, detailed list, view our report

Market challenge 
• High cost of multiplexed diagnostic assay equipment 
• For a full, detailed list, view our report

Market trend 
• Introduction of automated multiplexed PCR assays 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

 

Complete Report Details @ https://www.wiseguyreports.com/reports/1482538-global-high-density-multiplexed-diagnostic-assays-market-2017-2021

 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction 
• Market outline 

PART 05: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 

PART 06: Market segmentation by product 
• High-density multiplexed diagnostic assays (500-10,000 plex) 
• Very high-density multiplexed diagnostic assays (>10,000 plex) 
• Market overview 

PART 07: Market segmentation by end-user 
• Market overview 
• Clinical diagnostic laboratories 
• Hospitals and clinics 

PART 08: Geographical segmentation 
• High-density multiplexed diagnostic assays market in Americas 
• High-density multiplexed diagnostic assays market in EMEA 
• High-density multiplexed diagnostic assays market in APAC 

PART 09: Decision framework 

PART 10: Drivers and challenges 
• Market drivers 
• Infectious diseases 
• Oncology 
• Autoimmune diseases 
• Cardiac diseases 
• Allergies 
• Other application areas 
• Market challenges 

PART 11: Market trends 
• Introduction of automated multiplexed PCR assays 
• Higher adoption rate of molecular POCT 
• Improved sensitivity for the detection systems 
• Outsourcing from hospitals to reference laboratories 

PART 12: Vendor landscape 
• Competitive landscape analysis 

PART 13: Key vendor analysis 
• Thermo Fisher Scientific 
• Abbott 
• F. Hoffmann-La Roche 
• Key companies to watch 
• Other prominent vendors 

 ………..CONTINUED

 

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1482538

 

CONTACT US :

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)      

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industryresearch reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release